Bausch Stock Today


USD 5.80  0.21  3.76%   

Market Performance
0 of 100
Odds Of Distress
Over 62
Bausch Health is trading at 5.80 as of the 8th of August 2022, a 3.76 percent up since the beginning of the trading day. The stock's open price was 5.59. Bausch Health has more than 62 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Bausch Health Companies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of July 2022 and ending today, the 8th of August 2022. Please note, there could be an existing legal relationship between Bausch Health Companies (BHC) and BAUSCH HEALTH COMPANIES (VRX). Click here to learn more.
Fiscal Year End
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
29th of March 1994
Health Care
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company has 361.48 M outstanding shares of which 16.33 M shares are currently shorted by investors with about 3.01 days to cover. More on Bausch Health Companies

Moving together with Bausch Health

0.7CGCCanopy Growth Corp Aggressive PushPairCorr

Moving against Bausch Health

0.73ASRTAssertio Holdings Earnings Call  TodayPairCorr

Bausch Health Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Bausch Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bausch Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Bausch Health generated a negative expected return over the last 90 days
Bausch Health has high historical volatility and very poor performance
Bausch Health has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 8.33 B. Reported Net Loss for the year was (407 M) with profit before taxes, overhead, and interest of 6.04 B.
About 73.0% of the company shares are held by institutions such as insurance companies
Latest headline from Bausch Health Stock A Seemingly Disastrous State Of Affairs - Seeking Alpha
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Bausch Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bausch Health's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
ChairmanWilliam Humphries
Thematic IdeaPharmaceutical Products (view all)
Excise Tax ActivitiesAnimal Testing
Fama & French Classification
Average Analyst Recommendation
Analysts covering Bausch Health report their recommendations after researching Bausch Health's financial statements, talking to executives and customers, or listening in on Bausch Health's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Bausch Health Companies. The Bausch consensus assessment is calculated by taking the average forecast from all of the analysts covering Bausch Health.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Bausch Health Companies based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Bausch Health Companies financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares384.9 M358.9 M
Notably Up
Slightly volatile
Weighted Average Shares Diluted386.4 M358.9 M
Significantly Up
Slightly volatile
Net Cash Flow from Operations1.6 B1.4 B
Fairly Up
Slightly volatile
Total Assets33.4 B29.2 B
Fairly Up
Slightly volatile
Total Liabilities31.4 B29.2 B
Notably Up
Slightly volatile
Current Assets5.6 B5.6 B
Slightly Down
Slightly volatile
Current Liabilities4.9 B5.2 B
Notably Down
Slightly volatile
Total Debt24.2 B22.7 B
Notably Up
Slightly volatile
Return on Average Assets(0.0345)(0.032)
Significantly Down
Slightly volatile
Gross Margin0.790.716
Significantly Up
Slightly volatile
Asset Turnover0.290.284
Fairly Up
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Bausch Health's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Financial Strength
Bausch Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Bausch Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Bausch Health's financial leverage. It provides some insight into what part of Bausch Health's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Bausch Health's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Bausch Health deploys its capital and how much of that capital is borrowed.
Bausch Health cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 23.17 B in debt. Bausch Health Companies has a current ratio of 1.2, demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due. Debt can assist Bausch Health until it has trouble settling it off, either with new capital or with free cash flow. So, Bausch Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bausch Health Companies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bausch to invest in growth at high rates of return. When we think about Bausch Health's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

1.64 Billion
Bausch Health Companies (BHC) is traded on New York Stock Exchange in USA. It is located in 2150 St. ElzEar Boulevard West and employs 19,600 people. Bausch Health is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with total capitalization of 1.66 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bausch Health's market, we take the total number of its shares issued and multiply it by Bausch Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Bausch Health Companies runs under Healthcare sector within Drug Manufacturers—Specialty & Generic industry. The entity has 361.48 M outstanding shares of which 16.33 M shares are currently shorted by investors with about 3.01 days to cover. Bausch Health Companies has about 1.25 B in cash with 920 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.45.
Check Bausch Health Probability Of Bankruptcy
Bausch Health Companies retains a total of 361.48 Million outstanding shares. The majority of Bausch Health Companies outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bausch Health Companies to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bausch Health. Please pay attention to any change in the institutional holdings of Bausch Health Companies as this could imply that something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Bausch Ownership Details

Bausch Stock Price Odds Analysis

What are Bausch Health's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Bausch Health jumping above the current price in 90 days from now is about 89.26%. The Bausch Health Companies probability density function shows the probability of Bausch Health stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.6891 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bausch Health will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Bausch Health Companies is significantly underperforming DOW.
  Odds Below 5.8HorizonTargetOdds Above 5.8
10.70%90 days
Based on a normal probability distribution, the odds of Bausch Health to move above the current price in 90 days from now is about 89.26 (This Bausch Health Companies probability density function shows the probability of Bausch Stock to fall within a particular range of prices over 90 days) .

Bausch Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Bausch Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bausch Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bausch Health's value.
InstituionSecurity TypeTotal SharesValue
Segantii Capital Management LtdCommon Shares5.7 M47.7 M
Umb Bank NaCommon Shares1.1 MM
Simplex Trading LlcCall Options693.7 K5.8 M
Simplex Trading LlcPut Options441.9 K3.7 M
View Bausch Health Diagnostics

Bausch Health Historical Income Statement

Bausch Health Companies Income Statement is one of the three primary financial statements used for reporting Bausch's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Bausch Health Companies revenue and expense. Bausch Health Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Bausch Health Cost of Revenue is projected to increase significantly based on the last few years of reporting. The past year's Cost of Revenue was at 2.39 Billion. The current year Earning Before Interest and Taxes EBIT is expected to grow to about 421.9 M, whereas Consolidated Income is forecasted to decline to (1 B). View More Fundamentals

Bausch Stock Against Markets

Picking the right benchmark for Bausch Health stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bausch Health stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bausch Health is critical whether you are bullish or bearish towards Bausch Health Companies at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bausch Health without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Insider Screener Now


Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

Bausch Health Corporate Directors

Bausch Health corporate directors refer to members of a Bausch Health board of directors. The board of directors generally takes responsibility for the Bausch Health's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bausch Health's board members must vote for the resolution. The Bausch Health board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Sarah Kavanagh - Independent DirectorProfile
Richard DeSchutter - Independent DirectorProfile
Robert Hale - Independent DirectorProfile
Richard Schutter - Independent DirectorProfile

Invested in Bausch Health Companies?

You need to understand the risk of investing before taking a position in Bausch Health. The danger of trading Bausch Health Companies is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bausch Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bausch Health. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bausch Health Companies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Bausch Stock analysis

When running Bausch Health Companies price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Transaction History
View history of all your transactions and understand their impact on performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Bausch Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bausch Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.